Dr. Herder is Executive Vice President, Chief Operating Officer in Medivir AB (Stockholm,Sweden)and has been responsible for business development since 2017.She has more than 25years of experience in drug development as well as business development in the pharmaceuticalindustry. Prior to joining Medivir, Christina was the CEO of Modus Therapeutics, a Swedish drugdevelopment company. Since 2015 she has been a member of the Board of PCI BiotechHolding ASA (listed on Oslo Stock Exchange). Previous assignments include several seniorroles in Swedish Orphan Biovitrum (Sobi), Biovitrumas well as Pharmacia.Christina Herder holdsa doctorate from the Royal Institute of Technology in Stockholm and an Executive MBA fromStockholm University.